Therapeutic effect of interventional therapy for unprotected left main coronary artery lesions in aged patients

Zhong-Hai Wei1, Jie Song1, Lian Wang1

  • 1Department of Cardiology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.

Insights

Interventional therapy is effective and safe for elderly patients with unprotected left main coronary artery lesions. Left ventricular ejection fraction (LVEF) predicts cardiac death, while LVEF and estimated glomerular filtration rate (eGFR) predict major adverse cardiac events.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Geriatric Cardiology

Background:

  • Unprotected left main coronary artery (UPLM) lesions pose significant risks in elderly patients.
  • Assessing therapeutic options for UPLM lesions in older individuals is crucial for improving outcomes.

Purpose of the Study:

  • To evaluate the therapeutic efficacy and safety of interventional therapy for UPLM lesions in patients over 60 years old.
  • To identify predictors of cardiac death and major adverse cardiac events (MACE) in this patient cohort.

Main Methods:

  • A retrospective analysis of 61 patients over 60 undergoing UPLM interventional therapy from January 2012 to November 2013.
  • Follow-up averaged 14.6 months via telephone or outpatient visits to assess clinical outcomes.
  • Multivariate regression analysis (COX proportional hazards model) was used to identify independent predictors.

Main Results:

  • The study included 61 patients with an average age of 73.9 years, average LVEF of 47.7%, and median eGFR of 52 mL/min/1.73 mm(2).
  • The 30-day cardiac death rate was 6.6%, and the one-year MACE rate was 32.5%.
  • Left ventricular ejection fraction (LVEF) predicted 30-day cardiac death, while LVEF and estimated glomerular filtration rate (eGFR) predicted one-year MACE.

Conclusions:

  • Interventional therapy for UPLM lesions is a safe and effective treatment option for aged patients.
  • LVEF is a significant predictor of early cardiac death, and both LVEF and eGFR are important predictors of long-term MACE in this population.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
398
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
547
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
578
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
440
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
415
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
839